Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Registrati

Quotazioni in diretta

Home Investire Azioni Regno Unito LSE Novartis Ag (0K9E) Novartis Ag (0K9E) Notizie

0K9E

Novartis (0K9E)

HOME News News di Agenzia

News di Agenzia

Cerca Testo:

Da:

Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0K9E

1

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
29/01/2020	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...	LSE:0K9E	Novartis Ag
29/01/2020	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...	LSE:0K9E	Novartis Ag
29/01/2020	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...	LSE:0K9E	Novartis Ag
06/01/2020	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company	LSE:0K9E	Novartis Ag
16/12/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma	LSE:0K9E	Novartis Ag
05/12/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences	LSE:0K9E	Novartis Ag
24/11/2019	21:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...	LSE:0K9E	Novartis Ag
15/11/2019	21:06	UK Regulatory	NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...	LSE:0K9E	Novartis Ag
01/11/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...	LSE:0K9E	Novartis Ag
30/10/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update	LSE:0K9E	Novartis Ag
22/10/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Another Strong Quarter With Double Digit Sales Growth And Core1 Margin Expansion...	LSE:0K9E	Novartis Ag
22/10/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis, Encore Un Fort Trimestre: Croissance à Deux Chiffres Des Ventes Et Expansion De La Marge...	LSE:0K9E	Novartis Ag
22/10/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Verzeichnet Ein Weiteres Starkes Quartal Mit Zweistelligem Umsatz-wachstum Und Höherer Ke...	LSE:0K9E	Novartis Ag
08/10/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Receives Fda Approval For Beovu(R), Offering Wet Amd Patients Vision Gains And Greater Flu...	LSE:0K9E	Novartis Ag
02/10/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Positive 52-week Prevent Data Confirm Cosentyx(R) Efficacy In Addressing Entire Axspa Spec...	LSE:0K9E	Novartis Ag
29/09/2019	16:30	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Kisqali(R) Delivers Consistently Superior Overall Survival -- Monaleesa-3 Trial Demonstrat...	LSE:0K9E	Novartis Ag
17/09/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Positive 16-week Prevent Results Advance Potential New Indication For Patients...	LSE:0K9E	Novartis Ag
30/08/2019	07:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Ofatumumab Demonstrates Superiority Versus Aubagio(R) In Two Head-to-head Phase Iii Multip...	LSE:0K9E	Novartis Ag

Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0K9E

1

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea